Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,805
Closed -$246K 598
2025
Q4
$246K Sell
1,805
-105
-5% -$15.1K 0.02% 485
2025
Q3
$282K Buy
1,910
+129
+7% +$17.9K 0.03% 435
2025
Q2
$230K Sell
1,781
-138
-7% -$16.7K 0.03% 489
2025
Q1
$229K Buy
+1,919
New +$238K 0.03% 468
2024
Q4
Sell
-1,910
Closed -$258K 549
2024
Q3
$258K Buy
1,910
+55
+3% +$7.36K 0.03% 436
2024
Q2
$252K Buy
1,855
+169
+10% +$23K 0.03% 432
2024
Q1
$218K Buy
+1,686
New +$204K 0.03% 473

Other funds holding XYL

Wealth Alliance's XYL Position: Q1 2026 in Review

Wealth Alliance sold out of Xylem (XYL) in Q1 2026, closing a stake of 1,805 shares — an estimated $246K sold.

Wealth Alliance first reported a position in XYL in Q1 2024 and held it in 7 quarters. The position peaked at $282K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Wealth Alliance reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Wealth Alliance sold 1,805 Xylem shares in Q1 2026, an estimated $246K.
  • Wealth Alliance first reported a position in Xylem in Q1 2024 and held it in 7 quarters.
  • Wealth Alliance's Xylem position peaked at $282K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.